Publication

Article

Oncology & Biotech News
December 2010
Volume 4
Issue 12

Risk of Cancer from CT Scans

Author(s):

A retrospective study conducted at Stanford University found that the risk of cancer due to radiation from CT scans might be lower than previously determined.

A retrospective study conducted at Stanford University found that the risk of cancer due to radiation from CT scans might be lower than previously determined. The study reviewed Medicare claims of older adults from 1998-2005 to assess ionizing radiation exposure. The study stratified patients into two groups: those exposed to low doses and those exposed to high doses. Patients in the low-dose group had a .02% risk for developing radiationinduced cancer compared with .04% for patients in the high-dose group—significantly lower than previous estimates of 1.5% to 2%.

Related Videos
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, on progression patterns and subsequent therapies after lorlatinib in ALK-positive NSCLC.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss preclinical CNS data for the ROS1 inhibitor zidesamtinib.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for zidesamtinib in ROS1-positive non–small cell lung cancer.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on trastuzumab deruxtecan–based regimens in advanced HER2-positive GI cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on final overall survival data from the KEYNOTE-811 trial.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center